Recommended Global Gastroenterology Webinars & Conferences
Asia Pacific & Middle East
Liver Diseases 2025
About Conference
Welcome to the 16th International Conference on Liver Diseases & Hepatology, a premier event dedicated to the Innovations in Liver and Gastro Care. Held on March 24-25, 2025, in the vibrant city of London, UK. with the theme of “Innovations in Liver and Gastro Care”. This conference is a gathering of esteemed researchers, clinicians, healthcare professionals and experts from around the world, all driven by a shared mission to explore innovations in liver health and transform knowledge into impactful patient care.
The 16th International Conference on Liver Diseases & Hepatology is an unparalleled opportunity to expand your knowledge, engage in meaningful discussions and contribute to the advancement of liver health worldwide. We look forward to welcoming you to London in March 2025 for this transformative event. Together, let's explore innovations in liver health and work towards a healthier future for all.
Sessions & Tracks
Track 1: Gastroenterology
Gastroenterology is the branch of medicine focused on the digestive system and its disorders. This includes the organs from the mouth to the anus, such as the esophagus, stomach, intestines, liver, gallbladder, and pancreas. Gastroenterologists are medical specialists who diagnose and treat conditions affecting these organs, including diseases like gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), liver cirrhosis, and pancreatic disorders, among others. They use a variety of diagnostic techniques such as endoscopy, colonoscopy, and imaging studies to assess and manage gastrointestinal problems.
This includes the organs are:
- Esophagus
- Stomach
- Small intestine
- Large intestine (colon)
- Liver
- Gallbladder
- Pancreas
Gastrointestinal (GI) diseases refer to disorders that affect the various parts of the gastrointestinal tract (esophagus, stomach, small intestine, large intestine (colon), rectum, and anus) as well as accessory organs of digestion such as the liver, pancreas, and gallbladder. Some diseases which involve other parts of the GI tract can manifest in the mouth, alone or in combination. GI diseases affect millions of people around the world and are a leading cause of morbidity and mortality. Diarrhoea, abdominal pain, abdominal distension, nausea, vomiting, bloating, passage of excess wind or heartburn, change in bowel habit such as constipation are some of the most prevalent symptoms of gastrointestinal diseases. Early diagnosis and treatment are essential for preventing complications and improving quality of life.
Some common GI diseases and disorders include:
- Gastroesophageal Reflux Disease (GERD)
- Peptic Ulcers:
- Inflammatory Bowel Disease (IBD)
- Irritable Bowel Syndrome (IBS)
- Celiac Disease
- Gallstones
- Hemorrhoids and Cirrhosis
- Gastroenteritis
Track 3: Liver diseases
Liver diseases encompass a wide range of conditions that affect the liver's structure and function. These diseases can be caused by various factors including viral infections, excessive alcohol consumption, obesity, autoimmune diseases, and genetic predispositions.
Some common liver diseases include:
- Hepatitis
- Cirrhosis
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Alcoholic Liver Disease
- Liver Cancer
- Autoimmune Hepatitis
- Hemochromatosis and Wilson's Disease
- Gilbert's Syndrome
- Alpha-1 Antitrypsin Deficiency
Treatment for liver diseases varies depending on the specific condition and its severity. It may include lifestyle changes, medication, surgery, or liver transplantation. Early diagnosis and intervention are crucial for managing liver diseases effectively and preventing complications.
Track 4: Hepatitis
Hepatitis is an inflammation of the liver, often caused by viral infections, but it can also result from other factors like excessive alcohol consumption, certain medications, toxins, and autoimmune diseases. The liver is an important organ that helps the body digest nutrients, filter blood, and fight infections. The function of the liver might be harmed when it is inflamed or damaged. There are several types of viral hepatitis, including hepatitis A, B, C, D, and E. Each type is caused by a different hepatitis virus and has different modes of transmission and treatments.
Hepatitis A(HAV): Usually spreads through contaminated food or water, and in some cases, through close contact with an infected person. There's a vaccine available to prevent hepatitis A.
Hepatitis B (HBV): Transmitted through contact with infected blood, semen, or other bodily fluids. It can be prevented with a vaccine and managed with antiviral medications.
Hepatitis C (HCV): Also transmitted through contact with infected blood, commonly through sharing needles or syringes among injection drug users. Treatment for hepatitis C has advanced significantly in recent years with the introduction of direct-acting antiviral medications.
Hepatitis D (HDV): This type only occurs in conjunction with hepatitis B infection since it needs the hepatitis B virus to replicate. It is less common but can lead to more severe liver damage.
Hepatitis E (HEV): Often spread through contaminated water, and it's more prevalent in areas with poor sanitation. While it typically resolves on its own, it can be dangerous for pregnant women and people with weakened immune systems.
In addition to medication, lifestyle changes such as avoiding alcohol, maintaining a healthy diet, and getting regular exercise are important for managing hepatitis and preventing liver damage. It's crucial for individuals with hepatitis to work closely with healthcare providers to monitor the condition and determine the most appropriate treatment plan.
Track 5: Gastro Screening and Diagnosis
Gastro screening allows doctors to examine sections of the gastrointestinal system in order to discover potential issues. Each gastro screening approach has its own procedure, but they all require a thorough examination of specific sections of the gastrointestinal system. When a health care provider suspects a patient is suffering from a gastrointestinal (GI) disease or problem, or when a patient reports unexplained GI symptoms, technology can help through Diagnosis, screening and Imaging which help doctors learn more about the causes, symptoms, and severity of a disease. Gastrointestinal (GI) screening and diagnosis involve a variety of procedures and tests aimed at assessing the health and function of the digestive system. Here's an overview of common screening and diagnostic methods.
Screening: This involves tests or examinations performed on individuals who don't show any symptoms but may be at risk for GI diseases due to factors like family history, age, or lifestyle. Common screening methods include colonoscopy, upper endoscopy (EGD), stool tests for blood or pathogens, and imaging studies like CT scans or MRI.
Diagnosis: When symptoms such as abdominal pain, diarrhea, constipation, bleeding, or difficulty swallowing occur, diagnosis becomes crucial. It involves a series of tests to identify the underlying cause. Diagnosis can include physical exams, blood tests, imaging studies (like ultrasound or MRI), endoscopic procedures (colonoscopy, endoscopy), and biopsies (tissue samples).
Track 6: Gastrointestinal Endoscopy
Gastrointestinal endoscopy is a medical procedure that allows a doctor to examine the lining of the gastrointestinal tract, which includes the esophagus, stomach, small intestine, and colon. It's typically performed using a flexible tube with a light and camera at its tip, called an endoscope. During the procedure, the endoscope is inserted through the mouth or anus and carefully guided through the digestive tract. The camera allows the doctor to visualize the internal organs and detect any abnormalities such as inflammation, ulcers, bleeding, tumors, or other lesions.
Gastrointestinal endoscopy serves various diagnostic and therapeutic purposes. It can help diagnose conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, Crohn's disease, colorectal cancer, and more. Additionally, certain treatments can be performed during endoscopy, such as removing polyps, stopping bleeding, dilating narrowed areas, or taking tissue samples for biopsy.
Track 7: Gastrointestinal Oncology
Gastrointestinal oncology is a branch of medicine focused on the diagnosis and treatment of cancers that affect the gastrointestinal (GI) tract, which includes the esophagus, stomach, small intestine, colon, rectum, anus, liver, gallbladder, and pancreas. Gastrointestinal oncologists are specialized medical professionals who are trained to diagnose and manage cancers affecting these organs. They work closely with other specialists such as surgeons, medical oncologists, radiation oncologists, gastroenterologists, and pathologists to provide comprehensive care to patients with GI cancers. Treatment modalities may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and palliative care, depending on the type and stage of cancer.
This field deals with various types of cancers, including
- Colorectal cancer
- Gastric cancer
- Pancreatic cancer
- Liver cancer
- Other cancers that arise within the GI tract
Track 8: Gastrointestinal Surgery
Gastrointestinal surgery encompasses a wide range of surgical procedures that involve the digestive system, including the esophagus, stomach, small intestine, large intestine (colon), liver, pancreas, gallbladder, and rectum. These surgeries are performed to treat various conditions, ranging from benign diseases like gallstones and hernias to more serious conditions such as cancer and inflammatory bowel disease.
Some common types of gastrointestinal surgeries:
- Appendectomy
- Cholecystectomy
- Colectomy
- Esophagectomy
- Gastrectomy
- Hemorrhoidectomy
- Bariatric surgery
- Liver resection
- Pancreatectomy
- Splenectomy
These surgeries can be performed using traditional open surgery techniques or minimally invasive techniques such as laparoscopy or robotic-assisted surgery. Minimally invasive approaches often result in smaller incisions, less pain, shorter hospital stays, and quicker recovery times compared to open surgery. The choice of surgical approach depends on factors such as the patient's condition, the complexity of the procedure, and the surgeon's expertise.
Track 9: Gastroenterology & Pregnancy
Gastroenterology during pregnancy deals with the management of digestive issues that may arise in pregnant women. Pregnancy can bring about changes in the gastrointestinal system due to hormonal fluctuations and physical changes in the body, increased pressure on abdominal organs and altered eating habits during pregnancy. Common issues include nausea, vomiting (morning sickness), heartburn, constipation, and hemorrhoids.
Gastroenterologists work closely with obstetricians to ensure the health and well-being of both the mother and the developing fetus. They may recommend dietary changes, lifestyle modifications, and medications that are safe for use during pregnancy to alleviate symptoms. In some cases, more serious gastrointestinal conditions such as inflammatory bowel disease or gallstones may require specialized management to minimize risks to both the mother and the baby. Regular monitoring and communication between the gastroenterologist and obstetrician are essential to provide optimal care throughout pregnancy.
Track 10: Neuro Gastroenterology
Neurogastroenterology focuses on the study of the interactions between the nervous system and the digestive system. It deals with understanding how the brain, spinal cord, and nerves influence gastrointestinal function, and how gastrointestinal disorders can affect the nervous system. Researchers and clinicians in this field study the underlying mechanisms which often involve complex interactions between the brain, gut, and microbiome. This interdisciplinary field brings together expertise from neurology, gastroenterology, and psychology to better understand and treat conditions such as irritable bowel syndrome (IBS), functional dyspepsia, and other disorders of gut-brain interaction. Treatment approaches may include dietary modifications, medications, behavioral therapy, and interventions targeting the nervous system or gastrointestinal function.
- Interdisciplinary Approach
- Enteric Nervous System (ENS)
- Gut-Brain Axis
- Functional GI Disorders
- Neurotransmitters and Hormones
- Psychological Factors
Gastrointestinal (GI) inflammation refers to the body's response to irritation, injury, or infection within the gastrointestinal tract, which includes the esophagus, stomach, small intestine, and large intestine. Inflammation of the gastrointestinal tract can occur due to various reasons such as infections, autoimmune disorders, dietary factors, and medications. Symptoms may include Abdominal Pain, Diarrhea, Constipation, Nausea and Vomiting, Bloating and Gas and Rectal Bleeding. Common conditions involving GI inflammation include gastritis, gastroenteritis, inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis, and gastroesophageal reflux disease (GERD). Treatment approaches for GI inflammation depend on the underlying cause and severity of the condition.
Some of common treatment strategies:
- Medications (Antibiotics, Anti-inflammatory drugs, Proton pump inhibitors (PPIs), Antacids)
- Lifestyle Modifications (Dietary changes, Smoking cessation, Stress management)
- Surgery
- Probiotics
- Nutritional Support
Track 12: Liver Fibrosis and Cirrhosis
Liver fibrosis and cirrhosis are both conditions that affect the liver, but they represent different stages of liver disease.
Liver Fibrosis: This condition involves the accumulation of excessive scar tissue (fibrosis) in the liver. It typically occurs in response to chronic liver injury, such as from hepatitis C infection, chronic alcohol consumption, non-alcoholic fatty liver disease (NAFLD), or other causes. Fibrosis is the body's way of trying to repair liver damage. In the early stages, liver fibrosis may not cause noticeable symptoms, but as it progresses, it can lead to more severe liver dysfunction.
Cirrhosis: Cirrhosis is an advanced stage of liver fibrosis characterized by widespread scarring (fibrosis) and the distortion of the liver's normal structure. In cirrhosis, healthy liver tissue is replaced by scar tissue, which impairs the liver's ability to function properly. Cirrhosis is often irreversible and can lead to serious complications, including liver failure, portal hypertension (high blood pressure in the liver's portal vein system), ascites (accumulation of fluid in the abdomen), hepatic encephalopathy (brain dysfunction due to liver failure), and an increased risk of liver cancer.
Both liver fibrosis and cirrhosis can result from various causes, including chronic viral hepatitis (such as hepatitis B and C), excessive alcohol consumption, non-alcoholic fatty liver disease (NAFLD), autoimmune liver diseases, genetic disorders, and certain medications or toxins. Early detection and management of the underlying causes are crucial in preventing or slowing the progression of liver fibrosis to cirrhosis and reducing the risk of complications.
Track 13: Liver Cancer
Liver cancer is a serious condition where abnormal cells grow uncontrollably in the liver. It can develop from several different types of liver cells, leading to various forms of liver cancer. The most common type is hepatocellular carcinoma (HCC), which originates from hepatocytes, the main type of liver cell. Symptoms of liver cancer may include unexplained weight loss, loss of appetite, abdominal pain or swelling, jaundice (yellowing of the skin and eyes), fatigue, and nausea. However, in the early stages, liver cancer may not cause any noticeable symptoms. Risk factors for liver cancer include chronic infection with hepatitis B or C viruses, excessive alcohol consumption, fatty liver disease, exposure to aflatoxins (toxins produced by certain types of mold), and certain genetic conditions.
Treatment options for liver cancer depend on factors such as the stage of the cancer, the patient's overall health, and the underlying cause. They may include
- Surgery
- Liver transplantation,
- Chemotherapy
- Radiation therapy
- Targeted therapy
- Immunotherapy
- Regular screening for individuals at high risk is crucial
Track 14: Liver Transplantation and Liver Biopsy
Liver transplantation and liver biopsy are two medical procedures related to the liver, but they serve different purposes.
Liver Transplantation: Liver transplantation is a surgical procedure where a diseased or damaged liver is replaced with a healthy liver from a donor. It is usually performed in patients with end-stage liver disease or acute liver failure. Liver transplantation can be a life-saving treatment for those whose liver function is severely compromised. There are two main types of liver transplantation:
- Orthotopic Liver Transplantation (OLT)
- Living Donor Liver Transplantation (LDLT)
Liver Biopsy: Liver biopsy is a diagnostic procedure used to obtain a small sample of liver tissue for examination under a microscope. It helps in diagnosing various liver diseases and assessing the extent of liver damage. There are different methods of performing liver biopsy:
- Percutaneous Liver Biopsy
- Transjugular Liver Biopsy
- Laparoscopic Liver Biopsy
Both liver transplantation and liver biopsy are important tools in the management of liver diseases, but they serve different purposes: transplantation aims to replace a diseased liver with a healthy one, while biopsy helps in diagnosing liver conditions and guiding treatment decisions.
Track 15: Liver Regeneration and Stem Cell Therapy
Liver regeneration is a fascinating process where the liver can repair and replace damaged tissue. It's a highly orchestrated sequence of events involving various cell types and signaling pathways. While the liver has a remarkable ability to regenerate, severe or chronic damage can overwhelm this capacity, leading to liver dysfunction or failure.
Stem cell therapy holds promise as a potential treatment for liver diseases and injuries. Stem cells have the ability to differentiate into various cell types, including liver cells (hepatocytes), making them attractive candidates for regenerating damaged liver tissue. There are several types of stem cells being investigated for liver regeneration, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and adult stem cells such as mesenchymal stem cells (MSCs) and hepatic progenitor cells. Researchers are exploring different approaches to harness the regenerative potential of stem cells for liver therapy.
- Transplantation
- Indirect Effects
- Tissue Engineering
Track 16: Prebiotics and Probiotics
Prebiotics and probiotics are both essential components for maintaining a healthy gut, but they serve different roles.
Prebiotics are types of dietary fiber that serve as fuel for the beneficial bacteria in your gut. They are essentially food for probiotics. Prebiotics are found in many fruits, vegetables, and whole grains. Some common sources include bananas, onions, garlic, leeks, asparagus, oats, and barley. By consuming prebiotic-rich foods, you can help promote the growth and activity of beneficial bacteria in your gut.
Probiotics, on the other hand, are live microorganisms that provide health benefits when consumed in adequate amounts. These “good bacteria” are found in certain foods, such as yogurt, kefir, sauerkraut, kimchi, and other fermented foods. They can also be taken as dietary supplements. Probiotics help maintain a balanced gut microbiota by replenishing and supporting the population of beneficial bacteria.
Consuming a combination of prebiotic-rich foods and probiotic-containing foods or supplements can help promote digestive health, support the immune system, and may even have other benefits such as improving mood and reducing the risk of certain diseases. Consulting with a healthcare professional can provide personalized recommendations regarding their use.
Track 17: Gut Microbiome - Digestive Health
The gut microbiome refers to the vast community of microorganisms that inhabit the gastrointestinal tract, primarily the colon. These microorganisms include bacteria, viruses, fungi, and other microbes, which play a crucial role in maintaining digestive health and overall well-being. Maintaining a healthy gut microbiome involves various factors such as diet, lifestyle, and avoiding unnecessary antibiotics. Consuming a diverse range of fiber-rich foods, fermented foods (like yogurt, kefir, and sauerkraut), and prebiotics (such as onions, garlic, and bananas) can promote a healthy balance of gut bacteria. Disruptions to the gut microbiome such as through antibiotic use, poor diet, stress, or illness, can lead to dysbiosis, an imbalance in the microbial community.
The digestive system relies on the gut microbiome for various functions, including breaking down food particles that the body cannot digest on its own, synthesizing essential nutrients such as certain vitamins and short-chain fatty acids, and protecting against harmful pathogens. A balanced gut microbiome is essential for proper digestion and absorption of nutrients, as well as for regulating immune function and inflammation in the gut.
This gut imbalance has been linked to various digestive disorders, including
- Irritable bowel syndrome (IBS)
- Inflammatory bowel disease (IBD)
- Gastroesophageal reflux disease (GERD)
Track 18: Upper GI Tract, small & Large Intestine
Upper GI Tract: The upper gastrointestinal (GI) tract is the portion of the digestive system responsible for the initial stages of digestion. The upper GI tract consists of the mouth, esophagus, stomach, and duodenum (the first part of the small intestine). It plays a crucial role in breaking down food into smaller molecules that can be absorbed and utilized by the body for energy, growth, and repair. It also helps to protect the body from ingested pathogens by initiating immune responses and maintaining a barrier against harmful substances.
Small Intestine: The small intestine is the longest part of the GI tract and is divided into three sections: the duodenum, jejunum, and ileum. Most of the digestion and absorption of nutrients occur in the small intestine. It is crucial for the absorption of nutrients into the bloodstream, which are then distributed throughout the body to support various physiological functions. Additionally, the small intestine regulates the passage of undigested material into the large intestine, ensuring that only waste products reach the colon for elimination
Large Intestine: The large intestine, also known as the colon, is the final part of the digestive system. It includes the cecum, colon, rectum, and anus. It plays a crucial role in the absorption of water and electrolytes from the remaining indigestible food matter, forming solid waste (feces) for elimination. Understanding the anatomy and functions of the large intestine is crucial for maintaining digestive health and diagnosing and managing various gastrointestinal conditions.
The gallbladder is a small organ located beneath the liver that plays a crucial role in the digestive system by storing and concentrating bile, a fluid produced by the liver that helps in digesting fats. However, like any organ, the gallbladder is susceptible to various disorders and diseases which include Gallstones, Cholecystitis, Cholangitis, Biliary Dyskinesia, and Gallbladder Cancer. The symptoms of gallbladder diseases include Inflammation, infection, stones, and gallbladder blockage and continuous gripping or gnawing pain in the upper right abdomen near the rib cage, which can be severe and spread to the upper back, is the most common symptom.
Some treatments for gallbladder disorders and diseases:
- Medication
- Dietary Changes (Avoiding fatty, greasy foods that can trigger symptoms)
- Weight Management (Maintaining a healthy weight to reduce the risk of gallstone formation)
- Regular Exercise (Engaging in physical activity to promote gallbladder health and overall well-being)
Surgical Interventions (In many cases, surgery may be necessary to remove the gallbladder or gallstones. The two main surgical procedures are: 1. Cholecystectomy 2. ERCP (Endoscopic Retrograde Cholangiopancreatography)
Alternative Therapies (Herbal Remedies, Acupuncture)
The pancreas is a large gland that is located beneath the stomach and next to the small intestine. The main function of the pancreas is it aids digestion by releasing powerful digestive enzymes into the small intestine. So the enzymes Insulin and glucagon are released into the bloodstream. These hormones aid in the body's ability to regulate how it uses food for energy. When digestive enzymes start acting before the pancreas releases them, the pancreas can be harmed. Pancreatic diseases encompass a range of conditions, including pancreatitis (inflammation of the pancreas), pancreatic cancer, pancreatic cysts, and others. Treatment options vary depending on the specific disease and its severity.
- Pancreatitis
- Pancreatic Cancer
- Pancreatic Cysts
- Diabetes Management
- Pain Management
- Lifestyle Changes
Track 21: Gastro Emergency Care and Nursing
Gastrointestinal (GI) emergencies can encompass a wide range of conditions, from acute abdominal pain to gastrointestinal bleeding. One of the most prevalent appearances to an emergency department is gastrointestinal diseases and emergencies. Abdominal pain, nausea, vomiting, diarrhoea, and fever are all common symptoms observed at the emergency room. The discrepancy diagnosis varies depending on the patient's age and gender, the type of symptoms, systemic effects, recent travel or exposures, and the symptom description.
Trained Nurses play a crucial role in providing care to patients with these emergencies. These nurses are specialised in treating patients with digestive tract diseases, problems and injuries.
The outline of emergency care and nursing considerations for gastrointestinal issues:
- Assessment and Triage
- Pain Management
- Fluid and Electrolyte Management
- Monitoring and Observation
- Diagnostic Testing
- Medication Administration
- Patient Education and Emotional Support
- Discharge Planning
Advanced therapy and treatment techniques in gastroenterology encompass a wide range of approaches aimed at diagnosing, managing, and treating various gastrointestinal (GI) disorders.
Some notable advanced therapies and treatment techniques in the field:
- Endoscopic Ultrasound (EUS)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD)
- Radiofrequency Ablation (RFA)
- Transoral Incisionless Fundoplication (TIF)
- Balloon-assisted Enteroscopy
- Capsule Endoscopy
- Fecal Microbiota Transplantation (FMT)
These advanced therapies and treatment techniques in gastroenterology highlight the ongoing evolution of diagnostic and therapeutic approaches aimed at improving patient outcomes and quality of life and technology.
Clinical research in gastroenterology and liver diseases encompasses a wide range of studies focused on understanding, diagnosing, and treating conditions affecting the gastrointestinal (GI) tract and Liver. This field plays a crucial role in advancing medical knowledge and improving patient care in areas such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), liver diseases, gastrointestinal cancers and more.
Some important areas of clinical research in gastroenterology include:
- Inflammatory Bowel Disease (IBD
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Gastrointestinal Cancers
- Liver Cancers
- Functional Gastrointestinal Disorders (FGIDs)
- Endoscopy and Minimally Invasive Procedures
- Microbiome Research
- Nutrition and Diet
Overall, clinical research in gastroenterology is multidisciplinary, involving collaborations between gastroenterologists, hepatologists, surgeons, pathologists, radiologists, nutritionists, and other healthcare professionals. Through rigorous scientific investigation and clinical trials, researchers aim to advance our understanding of gastrointestinal disorders and improve outcomes for patients worldwide.
Artificial Intelligence (AI) and digital health technologies are revolutionizing the field of gastroenterology and hepatology offering innovative solutions for diagnosis, treatment, and patient care. The integration of AI into digital health initiatives in gastroenterology and hepatology holds great promise for enhancing patient care, optimizing clinical workflows, and advancing our understanding of GI disorders. As AI technology continues to evolve, we can expect to see further innovations that revolutionize the field and improve outcomes for patients with digestive health conditions.
The AI and digital health are impacting gastroenterology include:
- Diagnostic Assistance
- Predictive Analytics
- Personalized Treatment Plans
- Telemedicine and Remote Monitoring
- Patient Education and Engagement
- Data Analytics and Research
- Surgical Assistance
Market Analysis
LIVER DISEASES 2025 is the best platform for all recognized/ under- recognized scholastics in the field of Liver, Gastroenterology, Hepatology, Health specialists, analysts, educational scientists, Industry researchers, scientists to exchange about research and developments in grounds of Gastroenterology. The main focus of this meeting is to invigorate and globalize new thoughts and researches for treatment and to determine the current market for proceeding towards future of Gastro medicine, operational devices and diagnostics, with an accentuation on new technology that will be advantageous in the field of Gastroenterology and Hepatology.
The global gastrointestinal therapeutics market size was valued at USD 37.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.3% from 2023 to 2030. The increasing prevalence of gastrointestinal disorders such as IBS, Crohn’s disease, and ulcerative colitis and the rising demand for gastrointestinal (GI) drugs are the major factors driving the market growth. Moreover, the surge in R&D efforts by pharmaceutical companies to develop novel GI drugs and increasing product approvals are expected to enhance market growth during the forecast period.
According to the GI Alliance data from February 2021, it is estimated that around 20 million Americans suffer from chronic digestive diseases and over 62 million Americans are diagnosed with gastrointestinal diseases annually and the incidence of gastrointestinal disorders rises with age. Moreover, as per data published by the International Foundation for Gastrointestinal Disorders, Inc (IFFGD), the prevalence of GERD is 18-28% in North America, 23% in South America and 9-26% in Europe. Thus, the high prevalence of gastrointestinal diseases is likely to drive market growth in the coming years.
Young Research Award
Prestigious Award for Young Research’s at Liver Diseases 2025 – “Hepatology and Gastro”
Liver Diseases 2025 Committee is glad to announce “16th International Conference on Liver Diseases & Hepatology” on March 24-25, 2025 in London, UK. focusing on the theme: “Innovations in Liver and Gastro Care” Liver Diseases 2025 developments are maintaining their momentum. Liver Diseases Conference program delves into strategic discussions.
Liver Diseases 2025 Young Scientist Awards:
Liver Diseases 2025 Committee is intended to honour prestigious award for talented Young researchers, scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Hepatology and Gastro.
Young Research’s Awards at Liver Diseases 2025 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at Liver Diseases 2025 young research forum.
Benefits
- Young Scientist Award recombination certificate and memento to the winners.
- Our conferences provide best Platform for your research through oral presentations.
- Learn about career improvement with all the latest technologies by networking.
- Young Scientists will get appropriate and timely information by this Forum.
- Platform for collaboration among young researchers for better development.
- Provide an opportunity for research interaction and established senior investigators across the globe in the field.
- Share the ideas with both eminent researchers and mentors.
- It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.
Eligibility
- Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty with a minimum of 5 years of research experience
- Presentation must be into scientific sessions of the conference.
- Each Young Researcher / Young Scientist can submit only one paper (as first author or co-author).
- Age limit-Under 35yrs
All submissions must be in English.
Participation/Presentation Options
Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.
Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration.
Poster presentation: Student Poster Competition will be organized at the Endocrinology Conference 2024 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.
For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.
Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session.
E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.
Exhibition: Liver Disease 2025 has the opportunity to exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.
To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?
Send your queries to liverdiseases@asiameets.com
Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.
Send your proposal to liverdiseases@asiameets.com to know the available advertisement options and prices
Sponsor Liver Disease 2025
Premium Sponsorship package
Additional Sponsorship package
Mail the program manager at liverdiseases@asiameets.com or WhatsApp on (+44 2045861247) to know more about the sponsorship packages.
Abstract Submission Criteria & Eligibility
PRESENTATION REQUIREMENTS:
Authors presenting at the conference are required to cover their own registration, travel, and accommodation expenses. Please note that accepted abstracts will receive an acceptance email with instructions on how to register for the conference.
Abstracts will be compiled into conference books, which will be distributed to participants during the event.
In the event that a presenter is unable to attend, they must arrange for a qualified substitute to present their paper or poster. If such a change is needed, please notify our conference team promptly.
SUBMISSION OPTIONS:
Oral paper presentations will be allocated 30-minute time slots and will be organized into sessions based on thematic clustering. The keynote session will extend for 45 minutes, while workshops/special sessions will have duration of 60 minutes. Symposia will also be allotted 60 minutes, followed by a 5-minute Q&A session.
Graduate and Master’s students may submit their abstracts for consideration in the poster and e-poster presentation category.
PhD students are invited to submit abstracts for the special Young Researcher’s Forum (YRF), poster, and e-poster presentation category. It's important to note that the YRF category encompasses brief oral presentations specifically tailored for Ph.D. students.
Extended abstract: Here's a revised version of the instructions in the Abstract Template format:
Title: Submissions Utilizing the Abstract Template
Abstract: This abstract outlines the requirements for submissions utilizing the Abstract Template in the specified category. Papers submitted in this category may encompass original empirical research, theoretical development, reviews, or critiques. The format ensures consistency and clarity in presentation, facilitating comprehension and evaluation for reviewers and readers alike.
Keywords: Abstract Template, submissions, empirical research, theoretical development, reviews, critiques.
These abstracts follow the structure of the Abstract Template, providing a concise overview of the respective topics while adhering to the prescribed format.
Past Conference Report
Liver Diseases 2024
The “16th International Conference on Liver Diseases & Hepatology” hosted by Conference Series LLC was successfully held during January 25-26, 2024 at London, UK and was marked with the presence of the committee members, senior scientists, young and brilliant researchers, business delegates and talented students from various countries, who made this conference successful and productive.
This conference highlighted the theme “Exploring Innovations in Liver Health: From Research to Treatment” with the following scientific tracks:
- Hepatologists and Gastroenterologists
- Researchers and Scientists
- Surgeons and Transplant Specialists
- Oncologists
- Radiologists
- Pathologists
- Nurses and Allied Health Professionals
- Pharmaceutical and Biotech Industry Professionals
- Patient Advocates
- Medical Students and Trainees
We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference LIVER DISEASES 2024 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various latest and exciting innovations in all areas of Gastro & liver. LIVER DISEASES 2024 Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference.Conference Series LLC Ltd extends its warm gratitude to all the Honorable Guests and Keynote Speakers of “LIVER DISEASES 2024”.Conference Series LLC Ltd is privileged to felicitate LIVER DISEASES 2024 Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and the Moderators of the conference whose support and efforts made the conference to move on the path of success. Conference Series LLC LTD thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of gastro & liver .Conference Series LLC has taken the privilege of felicitating LIVER DISEASES 2024 Organizing Committee, and Keynote Speakers who supported the event.Conference Series LLC Ltd is glad to announce its “16th International Conference on Liver Diseases & Hepatology, we cordially welcome all the eminent researchers, Presidents, CEO’s, Gastro scientists and researchers in Hepatology sectors, Delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of liver and gastro with 20% abatement on the Early Bird Prices.Bookmark your dates for “ LIVER DISEASES 2025” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Conference. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC “Clinical Gastroenterology Journal” as a special issue.We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the conference, Conference Series LLC Ltd would like to announce the commencement of the “16th International Conference on Liver Diseases & Hepatology”.
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date March 24-25, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
Journal of Liver: Disease & Transplantation
Journal of Gastrointestinal & Digestive System
Clinical Gastroenterology Journal
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by